These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5538853)

  • 61. Manic behavior and levodopa.
    Pearlman CA
    N Engl J Med; 1971 Dec; 285(23):1326-7. PubMed ID: 5113740
    [No Abstract]   [Full Text] [Related]  

  • 62. Injected apomorphine and orally administered levodopa in Parkinsonism.
    Düby SE; Cotzias GC; Papavasiliou PS; Lawrence WH
    Arch Neurol; 1972 Dec; 27(6):474-80. PubMed ID: 4563448
    [No Abstract]   [Full Text] [Related]  

  • 63. [Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].
    Geissbuhler F; Eisenring JJ; Friedli P; Bartholini G; Tissot R
    Encephale; 1972; 61(2):127-48. PubMed ID: 4634903
    [No Abstract]   [Full Text] [Related]  

  • 64. Treatment of parkinsonism by amantadine and levodopa.
    Mawdsley C; Williams IR; Pullar IA; Davidson DL; Kinloch NE
    Clin Pharmacol Ther; 1972; 13(4):575-83. PubMed ID: 4557584
    [No Abstract]   [Full Text] [Related]  

  • 65. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration.
    Kales A; Ansel RD; Markham CH; Scharf MB; Tan TL
    Clin Pharmacol Ther; 1971; 12(2):397-406. PubMed ID: 4325251
    [No Abstract]   [Full Text] [Related]  

  • 66. Levodopa in parkinson's disease--Australian collaborative trial.
    Selby G
    Med J Aust; 1973 Mar; 1(12):577-85. PubMed ID: 4700544
    [No Abstract]   [Full Text] [Related]  

  • 67. MK 486 and levodopa in treatment of Parkinsonism.
    Lieberman AN; Derby BM; Feigenson J; Goodgold A; Nesbitte J; Resurreccion EC; Valdivia F
    Dis Nerv Syst; 1973; 34(4):167-71. PubMed ID: 4711885
    [No Abstract]   [Full Text] [Related]  

  • 68. Sustained-release levodopa.
    Woods AC; Glaubiger GA; Chase TN
    Lancet; 1973 Jun; 1(7816):1391. PubMed ID: 4122780
    [No Abstract]   [Full Text] [Related]  

  • 69. Pupillary effects of levodopa therapy. Development of anisocoria in latent Horner's syndrome.
    Weintraub MI; Gaasterland D; Van Woert MH
    N Engl J Med; 1970 Jul; 283(3):120-3. PubMed ID: 5423148
    [No Abstract]   [Full Text] [Related]  

  • 70. Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy.
    Kurtis MM; Franch O
    Parkinsonism Relat Disord; 2011 Dec; 17(10):774-6. PubMed ID: 21733737
    [No Abstract]   [Full Text] [Related]  

  • 71. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343
    [No Abstract]   [Full Text] [Related]  

  • 72. [Long-term treatment of Parkinsonism with L-dopa].
    Presthus J; Holmsen R
    Tidsskr Nor Laegeforen; 1972 Nov; 92(33):2262-6. PubMed ID: 4630916
    [No Abstract]   [Full Text] [Related]  

  • 73. Treatment failures with levodopa in Parkinsonism.
    Lieberman AN; Goodgold AL; Goldstein M
    Neurology; 1972 Nov; 22(11):1205-10. PubMed ID: 4673563
    [No Abstract]   [Full Text] [Related]  

  • 74. A double-blind study of the effects of levodopa in Parkinson's disease.
    Nakano KK; Tyler HR
    Neurology; 1971 Oct; 21(10):1069-74. PubMed ID: 4939556
    [No Abstract]   [Full Text] [Related]  

  • 75. Treatment of Parkinson's disease with Levodopa.
    Calhoun CL
    J Natl Med Assoc; 1972 Nov; 64(6):516-7 passim. PubMed ID: 4639943
    [No Abstract]   [Full Text] [Related]  

  • 76. Levodopa: alterations in behavior.
    Goodwin FK; Murphy DL; Brodie HK; Bunney WE
    Clin Pharmacol Ther; 1971; 12(2):383-96. PubMed ID: 4930867
    [No Abstract]   [Full Text] [Related]  

  • 77. Parkinson's disease. II.
    Mones RJ
    N Y State J Med; 1970 Nov; 70(22):2822-8. PubMed ID: 4920026
    [No Abstract]   [Full Text] [Related]  

  • 78. Long-term treatment of Parkinson's disease with levodopa.
    Campbell JB
    Neurology; 1970 Dec; 20(12):Suppl:18-22. PubMed ID: 4991656
    [No Abstract]   [Full Text] [Related]  

  • 79. Levodopa and psychometric test performance in parkinsonism-5 years later.
    Riklan M; Whelihan W; Cullinan T
    Neurology; 1976 Feb; 26(2):173-9. PubMed ID: 814483
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ; Somerville B
    Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.